Medical/Pharmaceuticals

Brii Biosciences Announces Agreement to Acquire VBI's IP Rights in BRII-179 (VBI-2601) and Plans to Initiate Technology Transfer to Expand Clinical and Commercial Supplies

Acquiring all intellectual properties relating to BRII-179 and eliminating future milestone and royalty payments to VBI, subject to achievement of certain activities Transferring manufacturing technologies of BRII-179 and PreHevbrio/PreHevbri to additional manufacturing sites and expanding footp...

2024-02-14 08:07 4159

PCA 500™-- the world's most efficient and versatile 12-lead ECG, receives FDA clearance for use in acute care

LOS ANGELES, Feb. 13, 2024 /PRNewswire/ -- QT Medical, a medtech company focusing on improving cardiac care with electrocardiogram (ECG or EKG), announces that it has received 510(k) clearance from the FDA for PCA 500™ use in acute care. PCA 500 was first 510(k) cleared in 2018 for professional a...

2024-02-14 00:30 1583

Datasea Reports Second Quarter Fiscal Year 2024 Financial Results and Operations Update - Second Quarter Revenue is $11.3 Million Versus $0.1 Million in the Year-Ago Period

BEIJING, Feb. 13, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a global technology company that develops and provides products utilizing intelligent acoustics including ultrasound, infrasound and directional sound, and provides 5G multimodal communication, upgrad...

2024-02-13 22:35 4029

Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³

Strong CSL Behring portfolio growth especially Ig FINANCIAL HIGHLIGHTS4 * Revenue $8.05 billion, up 11% at CC3 * NPAT $1.90 billion1, up 17% * NPAT $1.94 billion1 at CC3, up 20% * NPATA $2.02 billion1,2 , up 11% * NPATA $2.06 billion1,2 at CC3, up 13% * NPATA1,2 earnings per share $4.1...

2024-02-13 14:21 4132

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

VANCOUVER, BC, Feb. 13, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has executed the definitive  Asset Purchase Agreement datedFebruary 11th, 2024 to acquire the entire portfolio of discovery, preclinical and cli...

2024-02-13 03:26 4193

United Imaging Ramps Up U.S. Hiring, Opens a Seattle Office

The company continues to build strength in the U.S. market, already present in 35 states in its sixth year. HOUSTON, Feb. 12, 2024 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, is off to a fast start again in 2024, with 71 o...

2024-02-12 23:00 1658

DigniCap Delta receives market approval in Japan

LUND, Sweden, Feb. 12, 2024 /PRNewswire/ -- Dignitana announces that DigniCap Delta received market approval inJapan from the Ministry of Health, Labor and Welfare (MHLW). In Japan, Dignitana will provide DigniCap Delta to Konica Minolta as a medical device manufacturer, and Konica Minolta will p...

2024-02-12 16:40 2146

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

* Initial research project is with NDORMS, Botnar Research Institute, University of Oxford, focusing on accelerated aging in space * Dr. James L. Green, former Chief Scientist of NASA and Dr. Tara Ruttley, former Associate Chief Scientist of NASA to join Prenetics Scientific Advisory Board ...

2024-02-09 22:44 3144

YS Biopharma Announces US$40 Million Private Placement Financing

GAITHERSBURG, Md., Feb. 9, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma") along with its subsidiaries ("YS Group" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and th...

2024-02-09 19:30 6441

UFC WORLD CHAMPION JON JONES, LIFECYKEL LABS, CANTERBURY-BANKSTOWN BULLDOGS AND BETTER BREATHING DEVICES HOST ELITE PERFORMANCE/TRAINING DAY

SYDNEY, Feb. 9, 2024 /PRNewswire/ -- Jon Jones, UFC world champion and arguably the best MMA fighter to have ever existed is touringAustralia and has teamed up with Lifecykel Labs to host and facilitate a best-in-class performance training day which was held at the Canterbury-Bankstown Bulldogs h...

2024-02-09 18:09 3463

Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab

BENGALURU, India, Feb. 9, 2024 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced a five-year partnership with Sandoz AG ('Sandoz') which provides Sandoz the exclusive rights to promote, ...

2024-02-09 11:22 2508

E-Home Household Services Holdings Limited's subsidiary Zhongrun Pharmaceutical intends to acquire NBL (New Zealand) Limited to help expand the international market

FUZHOU, China, Feb. 8, 2024 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider inChina, announced that its subsidiary, Zhongrun (Fujian) Pharmaceutical Co., Ltd, intends to acquire NBL (New Zealand) Limited ("NB...

2024-02-08 22:00 4906

Tianlong's New Launch Gentier X3 Made its Appearance at Medlab Middle East 2024

DUBAI, UAE, Feb. 8, 2024 /PRNewswire/ -- The 4-day Medlab Middle East 2024 at the Dubai World Trade Center came to an end successfully onFebruary 8. MedLab is the largest exhibition of medical equipment in theMiddle East region, attracting visitors worldwide to experience the academic atmosphere ...

2024-02-08 21:00 3098

MGI Named a Finalist in the 2024 Edison Awards™ for Innovative DNBSEQ-T20x2* Gene Sequencer

SHENZHEN, China, Feb. 8, 2024 /PRNewswire/ -- MGI Tech , a company committed to building core tools and technology to lead life science, today announced its nomination as a finalist for the2024 Edison Awards™  in the "Health, Medical ...

2024-02-08 21:00 1754

DKSH Hong Kong Business Unit Healthcare Solidifies Long-Term Partnership with Church & Dwight

DKSH Hong Kong Business Unit Healthcare renews its partnership with Church & Dwight. DKSH continues to provide full agency services with the aim to expand the reach of Church & Dwight's Anusol product range inHong Kong. This collaboration demonstrates DKSH's unwavering commitment to "Healthcare f...

2024-02-08 19:38 3096

First in Human Dosed in Clinical Trial of ZMA001 for Treatment of Pulmonary Arterial Hypertension (PAH)

INCHEON, South Korea, Feb. 7, 2024 /PRNewswire/ -- Zymedi announced today that the first in human dosage of ZMA001, a monoclonal antibody being developed as a first-in-class treatment for Pulmonary Arterial Hypertension (PAH) has been initiated. The placebo-controlled phase 1 trial designed to a...

2024-02-08 11:53 1559

Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform

MELBOURNE, Australia , Feb. 8, 2024 /PRNewswire/ --.Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences, Inc. (U.S. OTC: QSAM) and its lead investigational drug Samarium-153-DOTMP (153Sm-DOTMP). QSAM is a United...

2024-02-08 06:11 2175

Datasea Regains Compliance with NASDAQ Minimum Bid Price Requirement

BEIJING, Feb. 7, 2024 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada incorporated digital technology corporation engaged in innovative business segments for intelligent acoustics and 5G messaging technology inChina announced today that, on February 6, 2024, it ...

2024-02-07 22:15 4154

Complete Genomics and seqWell Announce Codevelopment Partnership at AGBT

Companies will work together to offer fast, cost-effective ultra-high-throughput library preparation workflows SAN JOSE, Calif. and BEVERLY, Mass., Feb. 7, 2024 /PRNewswire/ -- Complete Genomics, a life sciences company specializing in end-to-end DNA sequencin...

2024-02-07 22:00 1772

SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain

SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer inSpain BOSTON and ROLLE, Switzerland and MADRID, Feb. 7, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, t...

2024-02-07 20:39 2323
1 ... 9596979899100101 ... 611

Week's Top Stories